*Department of Ophthalmology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan; and
†Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Correspondence: Yoshinori Oie, MD, PhD, Department of Ophthalmology, Osaka University Graduate School of Medicine, Room E7, Yamadaoka 2-2, Osaka 565-0871, Japan (e-mail: [email protected]).
Conflicts of interest statement: Y. Oie: Grant (Santen) and lecture fees (Alcon, Senju, and Santen); A. Miki: Lecture fees (Kowa, Pfizer, Santen, Alcon, Otsuka, Topcon, Ellex, HOYA, Scampo, Senju, and Sensimed); T. Soma: Lecture fees (HOYA, Santen, Otsuka, Nitto, Pfizer, Senju, and Alcon); S. Koh: Grant (SEED and Shire) and lecture fees (Santen, Otsuka, Oculus, and Johnson & Johnson); S. Kawasaki: Grant (Japan Agency for Medical Research and Development); M. Tsujikawa: Grant (Alcon); K. Nishida: Lecture fees (Japanese Tissue Engineering, Carl Zeiss, Alcon, Johnson & Johnson, HOYA, Novartis, Otsuka, Santen, Senju, Seed, Nidek, Pfizer, and Wakamoto). The remaining authors have no funding or conflicts of interest to disclose.